| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Roger D. Cone, Ph.D., Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201. E-mail: cone{at}ohsu.edu
The central melanocortin system has been demonstrated to play a pivotal role in energy homeostasis. Genetic disruption of this system causes obesity in both humans and mice. Previous experiments have shown that centrally-administered melanocortin agonists inhibit food intake and stimulate oxygen consumption. Here we report that centrally-administered melanocortin agonists also inhibit basal insulin release, and alter glucose tolerance. Furthermore, increased plasma insulin levels occur in the young lean MC4-R knockout (MC4-RKO) mouse, and impaired insulin tolerance takes place before the onset of detectable hyperphagia or obesity. These data suggest that the central melanocortin system regulates not only energy intake and expenditure, but also processes related to energy partitioning, as indicated by effects on insulin release and peripheral insulin responsiveness. Previous studies emphasize the role of excess adipose mass in the development of tissue insulin resistance, leading to type II diabetes. The data presented here show that defects in the central control of glucose homeostasis may be an additional factor in some types of obesity-associated type II diabetes.
This article has been cited by other articles:
![]() |
S. Park, S. M. Hong, S. R. Sung, and H. K. Jung Long-Term Effects of Central Leptin and Resistin on Body Weight, Insulin Resistance, and {beta}-Cell Function and Mass by the Modulation of Hypothalamic Leptin and Insulin Signaling Endocrinology, February 1, 2008; 149(2): 445 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. J. Ellacott, J. G. Murphy, D. L. Marks, and R. D. Cone Obesity-Induced Inflammation in White Adipose Tissue Is Attenuated by Loss of Melanocortin-3 Receptor Signaling Endocrinology, December 1, 2007; 148(12): 6186 - 6194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song and R. D. Cone Creation of a genetic model of obesity in a teleost FASEB J, July 1, 2007; 21(9): 2042 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lee, A. Kim, S. C. Chua Jr., S. Obici, and S. L. Wardlaw Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E121 - E131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Peter, J. R. Nicholson, D. Heydet, A.-C. Lecourt, J. Hoebeke, and K. G. Hofbauer Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2151 - R2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cone Studies on the Physiological Functions of the Melanocortin System Endocr. Rev., December 1, 2006; 27(7): 736 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi and S. O'Rahilly Genetics of Obesity in Humans Endocr. Rev., December 1, 2006; 27(7): 710 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Tallam, A. A. da Silva, and J. E. Hall Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin Hypertension, July 1, 2006; 48(1): 58 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Watson, S. Hahm, T. M. Mizuno, J. Windsor, C. Montgomery, P. E. Scherer, C. V. Mobbs, and S. R. J. Salton VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity Endocrinology, December 1, 2005; 146(12): 5151 - 5163. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Levin, C. Magnan, S. Migrenne, S. C. Chua Jr., and A. A. Dunn-Meynell F-DIO obesity-prone rat is insulin resistant before obesity onset Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R704 - R711. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Coll, B. G. Challis, M. Lopez, S. Piper, G. S.H. Yeo, and S. O'Rahilly Proopiomelanocortin-Deficient Mice Are Hypersensitive to the Adverse Metabolic Effects of Glucocorticoids Diabetes, August 1, 2005; 54(8): 2269 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, J. W. Bullen Jr., V. L. Stoyneva, and C. S. Mantzoros Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E625 - E632. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Santoro, E. M. del Giudice, G. Cirillo, P. Raimondo, I. Corsi, A. Amato, A. Grandone, and L. Perrone An Insertional Polymorphism of the Proopiomelanocortin Gene Is Associated with Fasting Insulin Levels in Childhood Obesity J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4846 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Savontaus, T. L. Breen, A. Kim, L. M. Yang, S. C. Chua Jr., and S. L. Wardlaw Metabolic Effects of Transgenic Melanocyte-Stimulating Hormone Overexpression in Lean and Obese Mice Endocrinology, August 1, 2004; 145(8): 3881 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kuo, A. A. da Silva, L. S. Tallam, and J. E. Hall Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation Hypertension, February 1, 2004; 43(2): 370 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.S. Farooqi and S. O'Rahilly Monogenic Human Obesity Syndromes Recent Prog. Horm. Res., January 1, 2004; 59(1): 409 - 424. [Abstract] [Full Text] |
||||
![]() |
S. Bluher, M. Ziotopoulou, J. W. Bullen Jr, S. J. Moschos, L. Ungsunan, E. Kokkotou, E. Maratos-Flier, and C. S. Mantzoros Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice Diabetes, January 1, 2004; 53(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Albarado, J. McClaine, J. M. Stephens, R. L. Mynatt, J. Ye, A. W. Bannon, W. G. Richards, and A. A. Butler Impaired Coordination of Nutrient Intake and Substrate Oxidation in Melanocortin-4 Receptor Knockout Mice Endocrinology, January 1, 2004; 145(1): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hochgeschwender, J. L. Costa, P. Reed, S. Bui, and M. B. Brennan Altered Glucose Homeostasis in Proopiomelanocortin-Null Mouse Mutants Lacking Central and Peripheral Melanocortin Endocrinology, December 1, 2003; 144(12): 5194 - 5202. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Mizuno, K. A. Kelley, G. M. Pasinetti, J. L. Roberts, and C. V. Mobbs Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice Diabetes, November 1, 2003; 52(11): 2675 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. HEISLER, M. A. COWLEY, T. KISHI, L. H. TECOTT, W. FAN, M. J. LOW, J. L. SMART, M. RUBINSTEIN, J. B. TATRO, J. M. ZIGMAN, et al. Central Serotonin and Melanocortin Pathways Regulating Energy Homeostasis Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 169 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. BRENNAN, J. L. COSTA, S. FORBES, P. REED, S. BUI, and U. HOCHGESCHWENDER {alpha}-Melanocyte-Stimulating Hormone Is a Peripheral, Integrative Regulator of Glucose and Fat Metabolism Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 282 - 287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cornish, K. E. Callon, K. G. Mountjoy, U. Bava, J.-M. Lin, D. E. Myers, D. Naot, and I. R. Reid alpha -Melanocyte-stimulating hormone is a novel regulator of bone Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1181 - E1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Farooqi, J. M. Keogh, G. S.H. Yeo, E. J. Lank, T. Cheetham, and S. O'Rahilly Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene N. Engl. J. Med., March 20, 2003; 348(12): 1085 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kuo, A. A. Silva, and J. E. Hall Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function Hypertension, March 1, 2003; 41(3): 768 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Heisler, M. A. Cowley, L. H. Tecott, W. Fan, M. J. Low, J. L. Smart, M. Rubinstein, J. B. Tatro, J. N. Marcus, H. Holstege, et al. Activation of Central Melanocortin Pathways by Fenfluramine Science, July 26, 2002; 297(5581): 609 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Pierroz, M. Ziotopoulou, L. Ungsunan, S. Moschos, J. S. Flier, and C. S. Mantzoros Effects of Acute and Chronic Administration of the Melanocortin Agonist MTII in Mice With Diet-Induced Obesity Diabetes, May 1, 2002; 51(5): 1337 - 1345. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |